Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diamyd in Newly Diagnosed Type 1 Diabetes
NCT00435981Phase 2Completed
- Sponsor
- Diamyd Medical
- Start
- Jan 2005
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Diamyd in type 1 diabetes mellitus (T1D), sponsored by Diamyd Medical. Started Jan 2005; status: completed.
02
Drugs
Diamyd
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00435981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435981.